News Focus
News Focus
icon url

Whalatane

12/02/21 9:44 PM

#362039 RE: rosemountbomber #362038

Better than AMRN for the next 31 days ?
Where to start
KSR because it’s more likely the LN play … not AUPH ( emphasis on MORE LIKELY )
CSR …. Because the new Covid variant won’t be as lethal as feared and it’s time for you and the wife to party with poster Lem in Vegas
UPST … cos it’s down so much the only direction is up … in other words … save me from overstaying my position there

Need I go on
CYTK and SWAV if U absolutely have to be on biotech or medtech

Kiwi
icon url

Whalatane

12/02/21 9:46 PM

#362040 RE: rosemountbomber #362038

Sorry that’s KZR … to hedge your AUPH buy out long shot

Kiwi
icon url

Whalatane

12/02/21 9:50 PM

#362041 RE: rosemountbomber #362038

Ok I’ll go on
CDYN because you know you should have diversified out of biotech
Kiwi
icon url

Whalatane

12/02/21 9:51 PM

#362042 RE: rosemountbomber #362038

Typo. GDYN

Kiwi
icon url

Whalatane

12/02/21 9:58 PM

#362044 RE: rosemountbomber #362038

The next 31 days for AMRN ?
Covid rages in Germany so sales reps , MD , lab tests delayed
Generics keep eating into US market
Co burns cash
Less than $ 1B in EV value …. U know some vultures will see value there as long as the R-IT patent stays intact and the EU market rolls out eventually
They are just waiting for all this tax loss selling you’re talking about

Kiwi